Functional Outcomes of the Low Vision Depression Prevention Trial in Age-Related Macular Degeneration
نویسندگان
چکیده
Purpose To compare the efficacy of behavioral activation (BA) plus low vision rehabilitation with an occupational therapist (OT-LVR) with supportive therapy (ST) on visual function in patients with age-related macular degeneration (AMD). Methods Single-masked, attention-controlled, randomized clinical trial with AMD patients with subsyndromal depressive symptoms (n = 188). All subjects had two outpatient low vision rehabilitation optometry visits, then were randomized to in-home BA + OT-LVR or ST. Behavioral activation is a structured behavioral treatment aiming to increase adaptive behaviors and achieve valued goals. Supportive therapy is a nondirective, psychological treatment that provides emotional support and controls for attention. Functional vision was assessed with the activity inventory (AI) in which participants rate the difficulty level of goals and corresponding tasks. Participants were assessed at baseline and 4 months. Results Improvements in functional vision measures were seen in both the BA + OT-LVR and ST groups at the goal level (d = 0.71; d = 0.56 respectively). At the task level, BA + OT-LVR patients showed more improvement in reading, inside-the-home tasks and outside-the-home tasks, when compared to ST patients. The greatest effects were seen in the BA + OT-LVR group in subjects with a visual acuity ≥20/70 (d = 0.360 reading; d = 0.500 inside the home; d = 0.468 outside the home). Conclusions Based on the trends of the AI data, we suggest that BA + OT-LVR services, provided by an OT in the patient's home following conventional low vision optometry services, are more effective than conventional optometric low vision services alone for those with mild visual impairment. (ClinicalTrials.gov number, NCT00769015.).
منابع مشابه
مروری بر روش های کمک بینایی به منظور بهبود کیفیت زندگی بیماران مبتلا به دژنراسیون وابسته به سن ماکولا
Background and purpose: Age related macular degeneration is the most common cause of sever visual impairment and blindness among adults over the age of 65 years in developed countries. The purpose of this study was to review the literature on using low vision aids in age related macular degeneration and their effects on their quality of life. Materials and methods: A comprehensive search of ...
متن کاملLow vision depression prevention trial in age-related macular degeneration: a randomized clinical trial.
PURPOSE To compare the efficacy of behavior activation (BA) + low vision rehabilitation (LVR) with supportive therapy (ST) + LVR to prevent depressive disorders in patients with age-related macular degeneration (AMD). DESIGN Single-masked, attention-controlled, randomized, clinical trial with outcome assessment at 4 months. PARTICIPANTS Patients with AMD and subsyndromal depressive symptoms...
متن کاملImproving function in age-related macular degeneration: design and methods of a randomized clinical trial.
Age-Related Macular Degeneration (AMD) is the leading cause of severe vision loss in older adults and impairs the ability to read, drive, and live independently and increases the risk for depression, falls, and earlier mortality. Although new medical treatments have improved AMD's prognosis, vision-related disability remains a major public health problem. Improving Function in AMD (IF-AMD) is a...
متن کاملThe Study of Serum Asymmetric Dimethylarginine Concentrations in the Different Paraoxonase Phenotypes of Exudative Age-related Macular Degeneration Disease
Background and Aims: Age-related macular degeneration (ARMD) is a degenerative retinal disorder that causes progressive loss of central vision in older adults. The study aimed to determine the effect of asymmetric dimethylarginine (ADMA) as oxidizing metabolite and paraoxonase (PON1) activity within its phenotypes as an antioxidant agent in the development of such multifactorial disease. Mater...
متن کاملPreventing depression in age-related macular degeneration.
CONTEXT Age-related macular degeneration is a prevalent disease of aging that may cause irreversible vision loss, disability, and depression. The latter is rarely recognized or treated in ophthalmologic settings. OBJECTIVE To determine whether problem-solving treatment can prevent depressive disorders in patients with recent vision loss. DESIGN Randomized, controlled trial. SETTING Outpat...
متن کامل